Genomic subtyping and therapeutic targeting of acute erythroleukemia

[1]  J. Swensen,et al.  Molecular characterization of cancers with NTRK gene fusions , 2018, Modern Pathology.

[2]  B. Tuch,et al.  ETV6-NTRK3 induces aggressive acute lymphoblastic leukemia highly sensitive to selective TRK inhibition. , 2018, Blood.

[3]  B. Tuch,et al.  Oncogenic TRK fusions are amenable to inhibition in hematologic malignancies , 2018, The Journal of clinical investigation.

[4]  Hamid Bolouri,et al.  The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions , 2017, Nature Medicine.

[5]  Cheng Cheng,et al.  THE GENOMIC LANDSCAPE OF PEDIATRIC AND YOUNG ADULT T-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA , 2017, Nature Genetics.

[6]  F. Meric-Bernstam,et al.  Targeting TRK family proteins in cancer , 2017, Pharmacology & therapeutics.

[7]  L. Pleyer,et al.  Clinical Outcomes of 217 Patients with Acute Erythroleukemia According to Treatment Type and Line: A Retrospective Multinational Study , 2017, International journal of molecular sciences.

[8]  D. Neuberg,et al.  Prognostic Mutations in Myelodysplastic Syndrome after Stem‐Cell Transplantation , 2017, The New England journal of medicine.

[9]  C. Bloomfield,et al.  High Frequency and Poor Outcome of Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia in Adults. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  Bob Löwenberg,et al.  Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. , 2017, Blood.

[11]  R. Axton,et al.  Activation of KLF1 Enhances the Differentiation and Maturation of Red Blood Cells from Human Pluripotent Stem Cells , 2017, Stem cells.

[12]  Mingming Jia,et al.  COSMIC: somatic cancer genetics at high-resolution , 2016, Nucleic Acids Res..

[13]  T. Bertrand.  Crystal Structures of Neurotrophin Receptors Kinase Domain. , 2017, Vitamins and hormones.

[14]  D. Arber.  Revisiting erythroleukemia , 2017, Current opinion in hematology.

[15]  Q. Wang,et al.  Exome sequencing identifies highly recurrent somatic GATA2 and CEBPA mutations in acute erythroid leukemia , 2015, Leukemia.

[16]  Christopher A. Miller,et al.  TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes. , 2016, The New England journal of medicine.

[17]  T. Haferlach,et al.  Application of an NGS‐based 28‐gene panel in myeloproliferative neoplasms reveals distinct mutation patterns in essential thrombocythaemia, primary myelofibrosis and polycythaemia vera , 2016, British journal of haematology.

[18]  J. Hernández-Rivas,et al.  Chromothripsis Is a Recurrent Genomic Abnormality in High-Risk Myelodysplastic Syndromes , 2016, PloS one.

[19]  K. Döhner,et al.  All-trans retinoic acid as adjunct to intensive treatment in younger adult patients with acute myeloid leukemia: results of the randomized AMLSG 07-04 study , 2016, Annals of Hematology.

[20]  P. Cin,et al.  Acute erythroid leukemia with <20% bone marrow blasts is clinically and biologically similar to myelodysplastic syndrome with excess blasts , 2016, Modern Pathology.

[21]  M. Lichtman.  The disappearance of acute erythroid leukemia: An act of legerdemain at the World Health Organization. , 2016, Blood cells, molecules & diseases.

[22]  Alex M. Fichtenholtz,et al.  Integrated genomic DNA/RNA profiling of hematologic malignancies in the clinical setting. , 2016, Blood.

[23]  Nicola D. Roberts,et al.  Genomic Classification and Prognosis in Acute Myeloid Leukemia. , 2016, The New England journal of medicine.

[24]  Mario Cazzola,et al.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. , 2016, Blood.

[25]  D. Muzny,et al.  Genomic Profiling of Pediatric Acute Myeloid Leukemia Reveals a Changing Mutational Landscape from Disease Diagnosis to Relapse. , 2016, Cancer research.

[26]  D. Birnbaum,et al.  Molecular characterization of acute erythroid leukemia (M6-AML) using targeted next-generation sequencing , 2016, Leukemia.

[27]  M. Loh,et al.  Truncating Erythropoietin Receptor Rearrangements in Acute Lymphoblastic Leukemia. , 2016, Cancer cell.

[28]  Zhifa Liu,et al.  Dunn Index Bootstrap (DIBS): A procedure to empirically select a cluster analysis method that identifies biologically and clinically relevant molecular disease subgroups , 2015, BMC Bioinformatics.

[29]  Dara L Aisner,et al.  An Oncogenic NTRK Fusion in a Patient with Soft-Tissue Sarcoma with Response to the Tropomyosin-Related Kinase Inhibitor LOXO-101. , 2015, Cancer discovery.

[30]  S. Chanock,et al.  Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite , 2015, Nature Genetics.

[31]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[32]  Prudence Mutowo-Meullenet,et al.  The GOA database: Gene Ontology annotation updates for 2015 , 2014, Nucleic Acids Res..

[33]  Jinghui Zhang,et al.  Reply to Artifacts in the data of Hu et al. , 2015, Nature Genetics.

[34]  M. McCarthy,et al.  Age-related clonal hematopoiesis associated with adverse outcomes. , 2014, The New England journal of medicine.

[35]  S. Gabriel,et al.  Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. , 2014, The New England journal of medicine.

[36]  Joshua F. McMichael,et al.  Age-related cancer mutations associated with clonal hematopoietic expansion , 2014, Nature Medicine.

[37]  Heather L. Mulder,et al.  Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. , 2014, The New England journal of medicine.

[38]  Heather L. Mulder,et al.  The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes , 2014, Nature Communications.

[39]  K. Horibe,et al.  Excess treatment reduction including anthracyclines results in higher incidence of relapse in core binding factor acute myeloid leukemia in children , 2013, Leukemia.

[40]  S. McKinney-Freeman,et al.  Nfix is a novel regulator of murine hematopoietic stem and progenitor cell survival. , 2013, Blood.

[41]  A. Kohlmann,et al.  Acute erythroid leukemia (AEL) can be separated into distinct prognostic subsets based on cytogenetic and molecular genetic characteristics , 2013, Leukemia.

[42]  Cheng Cheng,et al.  A genomic random interval model for statistical analysis of genomic lesion data , 2013, Bioinform..

[43]  S. Rutella,et al.  Results of the AIEOP AML 2002/01 multicenter prospective trial for the treatment of children with acute myeloid leukemia. , 2013, Blood.

[44]  Benjamin J. Raphael,et al.  Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. , 2013, The New England journal of medicine.

[45]  I. Panagopoulos,et al.  Fusion of ZMYND8 and RELA Genes in Acute Erythroid Leukemia , 2013, PloS one.

[46]  A. Snowman,et al.  Inositol Polyphosphate Multikinase Is a Coactivator of p53-Mediated Transcription and Cell Death , 2013, Science Signaling.

[47]  Benjamin E. Gross,et al.  Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.

[48]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[49]  M. Mathieu,et al.  The crystal structures of TrkA and TrkB suggest key regions for achieving selective inhibition. , 2012, Journal of molecular biology.

[50]  W. Hiddemann,et al.  Acute Myeloid Leukemia (AML): different treatment strategies versus a common standard arm--combined prospective analysis by the German AML Intergroup. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[51]  Luca Malcovati,et al.  Revised international prognostic scoring system for myelodysplastic syndromes. , 2012, Blood.

[52]  Li Ding,et al.  The Pediatric Cancer Genome Project , 2012, Nature Genetics.

[53]  David T. W. Jones,et al.  Genome Sequencing of Pediatric Medulloblastoma Links Catastrophic DNA Rearrangements with TP53 Mutations , 2012, Cell.

[54]  Kiran C. Bobba,et al.  The genetic basis of early T-cell precursor acute lymphoblastic leukaemia , 2012, Nature.

[55]  A. Kohlmann,et al.  The Interlaboratory RObustness of Next-generation sequencing (IRON) study: a deep sequencing investigation of TET2, CBL and KRAS mutations by an international consortium involving 10 laboratories , 2011, Leukemia.

[56]  P. Brousset,et al.  Identification of a transforming MYB-GATA1 fusion gene in acute basophilic leukemia: a new entity in male infants. , 2011, Blood.

[57]  Kenneth H. Buetow,et al.  Bioinformatics Applications Note Sequence Analysis Bambino: a Variant Detector and Alignment Viewer for Next-generation Sequencing Data in the Sam/bam Format , 2022 .

[58]  L. Medeiros,et al.  Pure erythroid leukemia: a reassessment of the entity using the 2008 World Health Organization classification , 2011, Modern Pathology.

[59]  N. Carter,et al.  Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development , 2011, Cell.

[60]  H. Kantarjian,et al.  Acute erythroid leukemia: a reassessment using criteria refined in the 2008 WHO classification. , 2010, Blood.

[61]  Robert B. Hartlage,et al.  This PDF file includes: Materials and Methods , 2009 .

[62]  Mark D. Robinson,et al.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..

[63]  T. Fioretos,et al.  Gene expression signatures in childhood acute leukemias are largely unique and distinct from those of normal tissues and other malignancies , 2010, BMC Medical Genomics.

[64]  C. Bloomfield,et al.  The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. , 2009, Blood.

[65]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[66]  Dinshaw J. Patel,et al.  Haematopoietic malignancies caused by dysregulation of a chromatin-binding PHD finger , 2009, Nature.

[67]  L. Hood,et al.  Dysregulated gene expression networks in human acute myelogenous leukemia stem cells , 2009, Proceedings of the National Academy of Sciences.

[68]  Christopher B. Miller,et al.  Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. , 2009, The New England journal of medicine.

[69]  S. Feig,et al.  Outcomes in CCG-2961, a children's oncology group phase 3 trial for untreated pediatric acute myeloid leukemia: a report from the children's oncology group. , 2008, Blood.

[70]  Christopher B. Miller,et al.  Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia , 2007, Nature.

[71]  E. S. Venkatraman,et al.  A faster circular binary segmentation algorithm for the analysis of array CGH data , 2007, Bioinform..

[72]  R. Gibbs,et al.  SNPdetector: A Software Tool for Sensitive and Accurate SNP Detection , 2005, PLoS Comput. Biol..

[73]  W. Hiddemann,et al.  Risk assessment by monitoring expression levels of partial tandem duplications in the MLL gene in acute myeloid leukemia during therapy. , 2005, Haematologica.

[74]  L. Strong,et al.  Gain of Function of a p53 Hot Spot Mutation in a Mouse Model of Li-Fraumeni Syndrome , 2004, Cell.

[75]  Cheng Li,et al.  dChipSNP: significance curve and clustering of SNP-array-based loss-of-heterozygosity data , 2004, Bioinform..

[76]  John D. Storey,et al.  Statistical significance for genomewide studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[77]  Martin Dugas,et al.  Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease. , 2002 .

[78]  A Kowal-Vern,et al.  Diagnosis and characterization of acute erythroleukemia subsets by determining the percentages of myeloblasts and proerythroblasts in 69 cases , 2000, American journal of hematology.

[79]  Robert Gray,et al.  A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .

[80]  K. Miyazono,et al.  Establishment and characterization of a unique human cell line that proliferates dependently on GM‐CSF, IL‐3, or erythropoietin , 1989, Journal of cellular physiology.

[81]  G Flandrin,et al.  Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. , 1985, Annals of internal medicine.

[82]  P. Rousseeuw.  Least Median of Squares Regression , 1984 .

[83]  T. Papayannopoulou,et al.  HEL cells: a new human erythroleukemia cell line with spontaneous and induced globin expression. , 1982, Science.

[84]  N. Mantel.  Evaluation of survival data and two new rank order statistics arising in its consideration. , 1966, Cancer chemotherapy reports.

[85]  W. Dameshek,et al.  Editorial—he Di Guglielmo Syndrome , 1958 .

[86]  F. Wilcoxon.  Individual Comparisons by Ranking Methods , 1945 .